Randall and colleagues [17] used MALDI imaging for a quantitative map distribution of EGFR inhibitor and tumor characteristics in a patient-derived xenograft model, which could possibly help to analyze the reasons for drug resistance. The gene discussed is EGFR; the disease is neoplasm.